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Introduction: Given one third of the human population have been
infected with tuberculosis, it is important to delineate the relation-
ship between tuberculosis and lung cancer. This study explored
whether contracting pulmonary tuberculosis is associated with an
increased risk of developing lung cancers.
Methods: In a cohort of 716,872 insured subjects, free from cancers,
aged 20 years and older, 4480 patients with newly diagnosed
tuberculosis were identified from the universal insurance claims in
1998–2000 and tracked until 2007 with the remaining insured
without tuberculosis. We compared the incidence of lung cancers
between the two cohorts and measured the associated hazard of
developing lung cancer.
Results: The incidence of lung cancers was approximately 11-fold
higher in the cohort of patients with tuberculosis than nontubercu-
losis subjects (26.3 versus 2.41 per 10,000 person-years). Cox
proportional hazard regression analysis showed a hazard ratio of
4.37 (95% confidence interval [CI]: 3.56–5.36) for the tuberculosis
cohort after adjustment for the sociodemographic variables or 3.32
(95% CI: 2.70–4.09) after further adjustment for chronic obstructive
pulmonary disease (COPD), smoking-related cancers (other than
lung cancer), etc. The hazard ratio increased to 6.22 (95% CI:
4.87–7.94) with the combined effect with COPD or to 15.5 (95% CI:
2.17–110) with the combined effect with other smoking-related
cancers.
Conclusions: This study provides a compelling evidence of in-
creased lung cancer risk among individuals with tuberculosis. The
risk may increase further with coexisting COPD or other smoking-
related cancers.
Key Words: Lung cancer, Tuberculosis, Chronic obstructive pul-
monary disease, Comorbidity, Retrospective cohort study.
(J Thorac Oncol. 2011;6: 32–37)
Lung cancers are among the neoplastic diseases with theworst prognosis. The etiology of the disease has been
associated with smoking, occupational exposure to arsenates,
nitrosamines, asbestos, and aromatics, and indoor exposures
to radon, and to fumes from fires or cooking stoves.1–4
Outdoor air pollutions also substantially contribute to the
burden of lung cancers in urban dwellers. Inflammation pro-
cesses have long been linked to cancer development.5,6 Among
intrinsic lung diseases with inflammatory components, chronic
obstructive pulmonary disease (COPD),7 asthma,8 and pulmo-
nary fibrosis9 have been linked to lung cancers. Tuberculosis
with more than 80% of the cases primarily affecting the lungs
entails a chronic inflammatory process. Coexistence of tuber-
culosis and lung cancers is not uncommon clinically.10,11
Nevertheless, a clear association of tuberculosis with lung
cancers remains to be established.
Several studies have examined the association between
tuberculosis and lung cancer using hospital/community-based
populations.12–21 Results of these studies were inconclusive.
Two studies were conducted in Montreal, Canada, in two
different periods (1979–1986 and 1996–2001) to evaluate
the association between previous lung diseases and lung
cancers.15 For tuberculosis, the evidence is inconsistent be-
tween these two studies. Littman et al.16 tracked a large
community population (n 17,698) with respiratory diseases
for a median follow-up of 9.1 years and found 1028 cases of
lung cancers. COPD, but not tuberculosis, was associated
with higher risk of lung cancers in this study. Among non-
smoker women in Hong Kong16 and the United States,17
preexisting pulmonary tuberculosis, asthma, pneumonia,
and chronic bronchitis were more frequently noted in
patients with lung cancers than without. Nevertheless, in
these two studies, only asthma, but not tuberculosis, bore
a significant impact. In a hospital-based case-control study
in Taiwan, Lee et al.18 found that history of pulmonary
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tuberculosis was an independent risk factor for lung can-
cers, outweighing chronic bronchitis.
To characterize the relationship between pulmonary
tuberculosis and lung cancers, a cohort study with popula-
tion-based large representative sample is highly desirable but
has rarely been conducted. The only published cohort study
on this topic to date was conducted among farmers in a
remote countryside in China using retrospective analysis
based on self-reported questionnaire data.22 The risk of lung
cancer mortality was eightfold (25 versus 3.1 per 1000
person-years) higher for those with tuberculosis than those
without in a population of 42,422 subjects. Nevertheless, this
study did not include review of medical records making it
possible for recall biases.
A recent systematic review of 41 studies was performed
to determine whether preexisting tuberculosis increased the
risk of developing lung cancers. Association of tuberculosis
with lung adenocarcinoma group was noted particularly in
nonwesternized countries.23 The impact of tuberculosis on
lung cancers varied among different ethnic groups and in
different regions. The inconclusive results led the authors
of this systematic review to call for more cohort studies
with larger sample sizes to confirm the association be-
tween tuberculosis and lung cancers.
To gain better knowledge on tuberculosis in relation-
ship to lung cancers, we conducted a population-based cohort
study using patient care data compiled into a large cohort of
1 million patients under the universal National Health Insur-
ance (NHI) program in Taiwan with a follow-up period of 7
to 9 years.
METHODS AND MATERIALS
Study Design and Sample
The NHI in Taiwan has registered all medical claims
since 1996 with insured identification numbers scrambled for
protecting patients’ privacy. Sets of information available for
this study include gender, birthdates, disease codes, health
care rendered, medications prescribed, admissions, dis-
charges, medical institutions, and physicians providing the
services and others. In this longitudinal cohort study in a
randomly selected population of 1 million insured subjects,
we identified all patients aged 20 years and older with a new
diagnosis of tuberculosis in 1998–2000 as the exposed cohort
and all people without tuberculosis history as the nonexposed
cohort also identified in 1998–2000. We also excluded pa-
tients with any cancer diagnosis to make sure participants
were cancer free at the start of both cohorts. Overall, 716,872
insured adult population were eligible for the prospective
analysis. This follow-up started in 2001 to include all incident
lung cancers or until censoring due to death, loss to follow-
up, or other causes by the end of 2007 to explore whether
individuals with tuberculosis were associated with an in-
creased risk of developing lung cancers.
Criteria and Definition
The International Codes of Diseases 9th Edition Clin-
ical Modification (ICD-9-CM) was used to identify the indi-
vidual health status. The exposure group consisted of patients
with diagnosis of tuberculosis (ICD-9-CM of 011 and A-code
of A020), and the nonexposure group consisted of all insured
without tuberculosis. Both groups were treated as fixed co-
horts. Even if a person developed tuberculosis in the years
2001–2007, they were still classified as being free of tuber-
culosis in the period 1998–2000 and remained in the same
cohort. We then identified new lung cancer cases (ICD-9-CM
of 162 and A-code of A101) from outpatient and inpatient
medical records. To ensure the accuracy of reimbursement
claims, the NHI system required experts review conducted
for every 50 to 100 claims. The institutions with false diag-
nosis are subject to penalties.24
In addition to tuberculosis, COPD, characterized by
chronic airway inflammatory process, has been linked to lung
cancers.7,25 Metabolic syndromes have also been linked to
several types of cancers.26,27 Diabetes was found to be asso-
ciated with breast cancer.28 Nevertheless, its relationship with
lung cancers remains controversial. Two articles addressed its
“protective” effect29,30 and another was negative.31 Impaired
glucose intolerance, elevated blood pressure, and dyslipide-
mia comprise the major components of metabolic syndromes,
which were, therefore, included in the comorbidity analysis.
Data Analysis
We first compared the distribution of sociodemo-
graphic factors between the cohorts with and without tuber-
culosis. The proportions of comorbidities were also compared
between the two cohorts. The incidence rates of lung cancers
were calculated in the follow-up period until the end of 2007
adjusted by the sociodemographic factors and comorbidities.
The duration of observation for each person was calculated
until lung cancer diagnosed or censored for death, migration,
or discontinued enrolment in the insurance system.
Crude and adjusted hazard ratios (HRs) with 95%
confidence intervals (CIs) for factors associated with lung
cancer risk were calculated using both the univariate and
multivariate Cox proportional hazard analyses with the vari-
ables categorized. Two multivariate Cox proportional hazard
models were used. The model 1 adjusted for age, sex, and
occupation. Model 2 further adjusted for diabetes, hyperten-
sion, dyslipidemia, and COPD. We also included in the
model 2 the smoking-related cancers other than lung cancer
(ICD-9-CM of 140–150, 157, 160–161, 189, and A08, A090,
A096, A100, A109, and A123). We further applied a multi-
variate Cox proportional hazard model to investigate the
combined effect of tuberculosis and COPD or other smoking-
related cancers on lung cancer risk. The Kaplan-Meier model
was used to compare the probabilities of being free from lung
cancer between the two cohorts. SAS software version 9.1
(SAS Institute Inc., Carey, NC) was used for data analyses
with two-sided probability values less than 0.05 considered
statistically significant.
RESULTS
The eligible study subjects included 4480 persons in the
tuberculosis cohort and 712,392 persons in the nontubercu-
losis cohort (Table 1). Compared with individuals without
tuberculosis, those with tuberculosis were dominated by
males (57.9 versus 49.2, p  0.0001), the elderly aged 60
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years or older (52.4% versus 19.0%, p  0.0001), and blue
collars (18.5% versus 13.9%, p  0.0001). Table 2 lists that
the patients with tuberculosis were more prevalent than the
nontuberculosis group with hypertension, dyslipidemia, dia-
betes mellitus, and COPD (p  0.0001 for all the listed
parameters). Patients who had other smoking-related cancers
were more prevalent in the tuberculosis cohort than in the
nontuberculosis cohort (p  0.008).
The follow-up results showed that patients with tuber-
culosis were 10.9 times more likely than nontuberculosis
patients to develop lung cancer (26.3 versus 2.41 per 10,000
person-years), with a HR of 3.32 (95% CI 2.70–4.09) after
controlling for demographic factors and comorbidities (Table
3). A separate analysis compared the mortalities between the
two cohorts and showed that the mortality was also much
higher in the patients with tuberculosis than in the nontuber-
culosis patients (51.1 versus 8.2 per 10,000 person-years)
(data not shown). The sex, age, and comorbidities adjusted
HR of deaths for patients with tuberculosis was 2.26 (95%
CI  1.96–2.61) higher. The Kaplan-Meier analysis showed
that the patients with tuberculosis had less proportion to be
free of lung cancer in comparison with nontuberculosis group
during a follow-up period by the end of 2007 (97.2% versus
99.8%, log-rank p  0.0001) (Figure 1).
In Table 4, the univariate Cox proportional regression
model shows that, in addition to tuberculosis, age, sex,
occupation, hypertension, dyslipidemia, diabetes, and COPD
were also significant factors relevant to the development of
lung cancers. After controlling for these variables, the pa-
tients with tuberculosis had a HR of 4.37 (95% CI: 3.56–
5.36) for lung cancers (model 1). When all comorbidities
were included in model 2 multivariate analyses, the HR
decreased to 3.32 (95% CI: 2.70–4.09). COPD and other
smoking-related cancers remained as significant independent
comorbidities associated with lung cancer development. This
model also shows that the risk of lung cancers increased as
age advanced, was higher in men than in women, and higher
in blue collar populations. Further analysis showed that
tuberculosis and COPD had a combined effect on the risk of
lung cancers with an HR of 6.22 (95% CI  4.87–7.94) (data
not shown). The HR increased to 15.5 (95% CI  2.17–110)
with the combined effect with other smoking-related cancers.
DISCUSSION
Previous studies on association between tuberculosis
and lung cancer using hospital/community-based populations
gave conflicting conclusions.12–22 The recent meta-analysis of
41 studies has concluded that tuberculosis link to lung can-
cers varied among different ethnic groups and in different
regions.23 The inconclusive results raise the need for cohort
studies with larger sample sizes to confirm the association
between tuberculosis and lung cancers. Nevertheless, a large
cohort study conducted in a remote country side in China,
based on self-reported questionnaire data, was without valid
TABLE 1. Comparison in Sociodemographic Factors











Females 361,749 (50.8) 1887 (42.1) 363,636 (50.7) 0.0001
Males 350,643 (49.2) 2593 (57.9) 353,236 (49.3)
Age (yr)
20–39 297,705 (41.8) 678 (15.1) 298,383 (41.6) 0.0001
40–59 279,312 (39.2) 1453 (32.4) 280,765 (39.2)
60–79 111,010 (15.6) 1601 (35.7) 112,611 (15.7)
80 24,365 (3.4) 748 (16.7) 25,113 (3.5)
Occupation
Publica 380,233 (53.4) 2053 (45.8) 382,286 (53.3) 0.0001
Labor 99,028 (13.9) 830 (18.5) 998,585 (13.9)
Business 173,473 (24.4) 986 (22.0) 174,459 (24.3)
Low incomeb 3029 (0.4) 31 (0.7) 3060 (0.4)
Others 56,629 (8.0) 580 (13.0) 57,209 (8.0)
a Government, education, and military.
b Insured income is lower than the level required for charging premium.
TABLE 2. Comparison in Comorbidity between Cohorts











No 572,900 (80.4) 2657 (59.3) 575,557 (80.3) 0.0001
Yes 139,492 (19.6) 1823 (40.7) 141,315 (19.7)
Hyperlipidemia
No 657,385 (92.3) 3832 (85.5) 661,217 (92.2) 0.0001
Yes 55,007 (7.7) 648 (14.5) 55,655 (7.8)
Diabetes
No 650,162 (91.3) 3654 (81.6) 653,816 (91.2) 0.0001
Yes 62,230 (8.7) 826 (18.4) 63,056 (8.8)
COPD
No 638,130 (89.6) 2505 (55.9) 640,635 (89.4) 0.0001
Yes 74,242 (10.4) 1975 (44.1) 76,237 (10.6)
Smoking-related
cancer
No 709,926 (99.6) 4454 (99.4) 714,380 (99.6) 0.008
Yes 2466 (0.4) 26 (0.6) 2492 (0.4)
a Missing value: 11 in urbanization.
b ICD-9-CM and A codes for hypertension were 401, 402, 403, 404, A260, A269;
for hyperlipidemia 272.0, 272.1, 272.2, 272.3, 272.4, A189; for diabetes 250, A181; for
COPD 491, 492, 496, A323.01, A323.03, A325; and for smoking-related cancer
140–150, 157, 160–161, 189, A08, A090, A096, A100, A109, A123.
COPD, chronic obstructive pulmonary disease.
TABLE 3. Incidence of Lung Cancer between Cohorts with
and without Tuberculosis
Tuberculosis Population Person-Years Cancer, n
Incidence
Ratea
No 712,392 6,571,088 1584 2.41
Yes 4480 37,951 100 26.3
a Per 10,000 person-years.
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confirmation of diagnosis for both tuberculosis and lung
cancer.22
This cohort study explored the longitudinal association
between tuberculosis and lung cancer risk using a nationwide
population-based sample of patients and complete ascertain-
ment of care that are verified with stringent NHI claim
procedures. Our analyses revealed that the incidence of lung
cancer is much greater in patients with tuberculosis than in
the general population, with an adjusted HR of 3.32 during a
follow-up of 7 to 9 years. It is also not surprise to observe a
much higher mortality in the tuberculosis cohort.
Results from this study are consistent with the report by
Gao and coworkers.32 that lung cancers were more frequently
found in recent survivors of tuberculosis infection. The risk is
higher for men than for women and much higher for the
elderly. The data also show tuberculosis is an independent
predictor of lung cancer risk, stronger than COPD. The
changing incidence shows a trend of lung cancer shifting
from developed to less-developed countries,33,34 where tuber-
culosis poses a major health risk because of poverty, high
population density, inadequate living environment, and less
accessibility to health care. High-smoking prevalence and
inadequate ventilated stove in houses point to a potential
health burden of lung cancer risk associated with tuberculosis
in developing countries. In these countries, the populations
are also aging with tuberculosis more prevalent in men. These
features together with results presented in this study heighten
the need for the developing countries to control tuberculosis.
Smoking and air pollutions are the two major risk
factors causing airway diseases by repeatedly irritating respi-
ratory epithelium, resulting in a chronic inflammatory condi-
tion. The link of chronic inflammation to the lung cancer
development has been demonstrated in animal models.35,36
COPD is a known risk for lung cancer. Cohort studies have
shown the association of COPD with lung cancers.37 It has
been reported that smokers with COPD had increased risk of
developing lung cancers by 1.3-fold to 4.5-fold in comparison
with smokers without COPD.37–39 Our analysis shows a
similar trend for COPD to increase the risk of lung cancers
with a HR of 2.30 (Table 4). The combined effect of tuber-
culosis and COPD increased the HR of lung cancer risk from
3.32 to 6.22, a risk measure comparable to smoking, the
major etiologic factor of lung cancer.40,41
This causal association between chronic inflammatory
conditions and lung cancers has been observed not only
clinically but also in a mice model. Using mutated K-ras
restricted to Clara cells of the conducting airway,
Moghaddam et al.35 reported that a chronic inflammatory
airway, mimicking COPD condition, promoted cancer pro-
gression. The infected sites of tuberculosis are under a
chronic inflammatory condition with inflammatory cells and
mediators that may facilitate carcinogenesis.
The longitudinal survey applied in this study is a better
approach in establishing a link of tuberculosis to lung can-
cers. It avoids the selection and recall biases in previous
cross-sectional and case-control studies.12–14,17,21 The popu-
lation-based insurance data allow this study to avoid recall
biases inherent to a previous self-reported questionnaire
study, which has been the only cohort study on association of
tuberculosis to lung cancers published to date.22 The larger
representative sample sizes collected in this study provide a
more reliable statistical power for assessing the increase in
lung cancer risk in patients with tuberculosis, when compared
with a control cohort without tuberculosis.
Using a nationwide insurance database for an epidemi-
ology study, the accuracy of clinical coding could be ques-
tioned. Tuberculosis is one of the communicable diseases
under intense national surveillance in Taiwan. Reporting
patients with tuberculosis is mandatory and is enforced by the
Department of Health in Taiwan. Cases reported to the Center
for Disease Control, Department of Health, were under the
World Health Organization recommended Directly Observed
Therapy Short-Course Care.
The diagnosis of cancers, including lung cancer, enti-
tles the patients to qualify for special health care privileges in
the class of “major critical diseases” in Taiwan’s NHI system.
Once a patient is claimed to have this disease entity; copay-
ments for health care are waived. This health benefit program
FIGURE 1. Kaplan-Meier curves for probabilities
of study patients who remained in the study
cohorts with and without tuberculosis.
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has been under stringent NHI auditing to avoid abuse or
frauds. Thus, results derived from the NHI database for the
diagnosis of tuberculosis and lung cancer are reliable.
In this study, none of the three metabolic syndrome-
related comorbidities was significantly associated with the
lung cancer risk in the multivariate analysis. There is a
significant collinearity among the components of the meta-
bolic syndrome, supporting the validity of the data retrieved
from the NHI cohorts. The findings that metabolic syndrome-
related comorbidities did not bear any weight on lung cancer
development in these cohorts support the contention that a
close association of tuberculosis with lung cancer is not a
chance observation.
There are potential limitations in this study. First, the
major concern in this study is that the smoking data of the
study cohorts were available only for the smoking cessation
history. Some studies have addressed the positive association
between smoking and tuberculosis.40,42 The estimate of
smoking is an important issue in the risk measurement of lung
cancers.40 The prevalence of smoking in Taiwan has been in
the range of 50 to 60% in men and 3 to 4% in women.43,44 We
used COPD and other smoking-related cancer to substitute
smoking as one of covariates in the adjustment measures.
This study showed that patients with other smoking-related
cancers were more prevalent in tuberculosis cohort. A case-
control study has indicated that 40% of patients with tuber-
culosis in Taiwan were smokers.45 A lower smoking rate in
patients with tuberculosis reflects greater efforts for this
group to quit smoking. Thus, the confounding impact of
smoking on the risk of lung cancer may be lower in the
tuberculosis group. A higher risk of lung cancer in men than
in women may reflect the smoking impact. Smoking has been
associated with metabolic syndrome.46 The negative associ-
ations between metabolic syndrome-related comorbidities
and lung cancer risk may also alleviate the potential bias that
is not adjusted without smoking data.
Second, even if tuberculosis is associated with lung
cancers, more questions could be raised. Does tuberculosis
affects some types of lung cancer but not others? Clinically,
squamous cell carcinoma (SCC) was found in more than 50%
of cases with coexistence of tuberculosis and lung cancers.11
SCC of lung was also found in mice subjected to chronic
infection of mycobacterial tuberculosis.36 A recent meta-
analysis of epidemiological data, however, revealed the as-
sociation was only significant with adenocarcinoma but not
SCC.23 Without information on lung cancer types, whether
tuberculosis is preferentially associated with select types of
lung cancer cannot be addressed based on results derived
from this study. Finally, there is a remote possibility that a
small number of patients with tuberculosis may have the
disease before being selected into the cohorts because of
receiving no medical care until 1998–2000. It is likely,
however, the bias will affect both groups with and without
lung cancer. Furthermore, 1584 patients with lung cancer in
the nontuberculosis cohort had received 2480 person-times of
x-ray examinations, whereas there were 1973 person-times
for the 100 patients in the tuberculosis cohort necessary for
the treatment progress. It is possible the frequent x-ray
examinations may increase the risk of lung cancer as well.
In conclusion, this nationwide population-based cohort
study provides evidence supporting the contention that pa-
tients with pulmonary tuberculosis carried higher risk of
developing lung cancers. COPD and smoking enhanced the
risk of lung cancer further in patients with tuberculosis.
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20–39 1.00 (reference) 1.00 (reference) 1.00 (reference)
40–59 13.0 (9.02–18.8) 12.9 (8.94–18.6) 12.0 (8.31–17.3)
60–79 73.4 (51.3–105) 69.1 (48.2–98.8) 52.2 (36.2–75.3)
80 168 (117–242) 143 (99.2–207) 92.8 (63.5–136)
Sex
Females 1.00 (reference) 1.00 (reference) 1.00 (reference)
Males 1.77 (1.60–1.95) 1.74 (1.57–1.92) 1.68 (1.52–1.86)
Occupation
Publica 1.00 (reference) 1.00 (reference) 1.00 (reference)
Labor 2.62 (2.33–2.96) 1.21 (1.07–1.37) 1.14 (1.01–1.30)
Business 1.08 (0.95–1.23) 1.03 (0.90–1.17) 1.01 (0.88–1.15)
Low income 2.08 (13.15–3.78) 1.43 (0.79–2.61) 1.30 (0.71–2.36)
Others 2.26 (1.95–2.63) 1.17 (0.995–1.37) 1.09 (0.93–1.28)
Tuberculosis
No 1.00 (reference) 1.00 (reference) 1.00 (reference)
Yes 11.9 (9.73–14.6) 4.37 (3.56–5.36) 3.32 (2.70–4.09)
Hypertension
No 1.00 (reference) 1.00 (reference)
Yes 5.31 (4.82–5.84) 1.11 (0.99–1.24)
Hyperlipidemia
No 1.00 (reference) 1.00 (reference)
Yes 2.45 (2.17–2.80) 1.05 (0.92–1.20)
Diabetes
No 1.00 (reference) 1.00 (reference)
Yes 3.31 (2.96–3.71) 1.07 (0.95–1.20)
COPD
No 1.00 (reference) 1.00 (reference)
Yes 6.15 (5.59–6.78) 2.30 (2.07–2.55)
Smoking-related
cancer
No 1.00 (reference) 1.00 (reference)
Yes 4.67 (3.17–6.88) 2.06 (1.40–3.03)
a Government, education, and military.
COPD, chronic obstructive pulmonary disease; HR, hazard ratio; CI, confidence
interval.
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